# A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study

> **NCT00360087** · PHASE3 · TERMINATED · sponsor: **Actelion** · enrollment: 236 (—)

## Conditions studied

- Pulmonary Hypertension
- Sickle Cell Anemia

## Interventions

- **DRUG:** Bosentan

## Key facts

- **NCT ID:** NCT00360087
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** 2007-08
- **Final completion:** 2007-12
- **Target enrollment:** 236 (—)
- **Why stopped:** Slow enrollment
- **Last updated:** 2025-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00360087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00360087, "A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00360087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*